COVID-19 update included
The content of this report will be updated with the latest scenarios based on the global COVID-19 Pandemic
Key Findings
The medical and surgical robotics global market is anticipated to inflate at a CAGR of 17.64% during the forecast period. Technological advancements in the robotics industry and acceleration in demand for minimal or non-invasive surgeries are the primary factors driving the medical and surgical robotics market across the globe.

Market Insights
The global medical and surgical robotics market is segmented on the basis of type and application. The type market is segregated into medical robotics, and surgical robotics and computer-assisted surgery. The application market is segmented into cardiac, gastrointestinal, urology, orthopedic, neurosurgical, ENT, prosthetic, multipurpose/others.
The requirement of robots in surgeries for assistance is rising across the globe. This demand is accelerating the growth of the medical and surgical robotics market in the future. The prime factor developing the demand for medical robots is the surge in healthcare expenditure. The investment in robotics technology, increase in the preference for minimally invasive surgery, mortality rates, and lifestyle diseases are some of the dominant drivers of the market. Contrarily, the expense difference between the surgery by robotic machines and human being varies which act as growth restraints for the market.

Regional Insights
North America is expected to generate the largest market share for global medical and robotics market by 2026. This growth is due to the development of surgical robots in hospitals, and pharmacy robots. The Asia Pacific is the most rapidly evolving region during the forecast years, resulting in a great opportunity for the medical and surgical robotics market. Europe is acknowledged leader in providing professional service robotics with Germany accounted for largest medical technology market.

Competitive Insights
The dominant players in the medical and surgical robotics market are Abbott Diagnostics, Accuray Inc., Aesynt Inc. (Acquired By Omnicell, Inc.), Agilent Technologies, Aurora Biomed, Baxter International, Biotek Instruments, CareFusion (Partnered With Becton, Dickinson And Company (BD), Hansen Medical, Inc., Hocoma Ag, Intuitive Surgical, Mazor Robotics, Kirby Lester, Rewalk Robotics, Irobot Corporation.